Go, Epifania C.
HRN: 00-02-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2025
CEFTAZIDIME 1GM (VIAL)
10/29/2025
11/05/2025
IV
2g
OD
CELLULITIS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes